Abstract
Objectives To determine factors that predict OSA therapy outcomes with auto-titrating positive airway pressure (APAP).
Methods We sequentially grouped patients from a retrospective cohort based on APAP efficacy (sufficiently vs. insufficiently treated; insufficiently treatment defined as residual AHI of ≥ 5); therapy adherence (compliant vs. non-compliant, non-compliance defined as < 70% usage for ≥ 4 hours/night); and therapy outcomes (optimal vs non-optimal (non-optimal outcomes defined as non-compliant and insufficiently treated). We subsequently compared each group.
Results The insufficiently treated were older (68.4 ± 12.5 vs. 60.4 ± 13.1 years, p < 0.01) and had lower BMI (31.9 ± 6.3 vs.37.9 ± 9.1 kg/m2, p < 0.01). They had higher baseline central apnea indices (CAI), longer leaks, higher peak pressures and were less compliant.
The non-compliant were younger (61.1 ± 12.6 vs. 65.5 ± 13.2 years, p = 0.03) and comprised more females (56.1 vs. 43.9%, p = 0.04). The leak duration per usage hour was higher in the non-compliant (13.9 ± 42.1 vs. 1.83 ± 3.53 minutes/hour, p < 0.01). The non-optimally treated had lower BMI, longer leaks and shorter nightly usage.
Following multivariate analysis, the aforementioned variables except age were predictive of higher residual AHI, while age and gender predicted compliance.
Conclusions Various demographic and clinical factors were predictive of treatment efficacy and adherence. Overall, lower BMI, longer leaks and shorter nightly usage predicted poor therapy outcomes.
Competing Interest Statement
Stuart F Quan is a consultant for Jazz Pharmaceuticals, Bryte Bed, Best Doctors and Whispersom. The other author has no conflicts of interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of Brigham and Women's Hospital gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
This study was conducted at the Brigham and Women’s Hospital in Boston MA
All authors have seen and approved the manuscript
There was no financial support for any of the authors
Conflicts of Interest
Stuart F Quan is a consultant for Jazz Pharmaceuticals, Bryte Bed, Best Doctors and Whispersom.
The other author has no conflicts of interest.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- CPAP
- Continuous Positive Airway Pressure
- APAP
- Auto-titrating Positive Airway Pressure
- OSA
- Obstructive Sleep Apnea
- AHI
- Apnea Hypopnea Index
- RAHI
- Residual AHI
- BAHI
- Baseline AHI
